INCRUSE ELLIPTA 55 micrograms, powder for inhalation in a single-dose container 30 doses
Active ingredients: Umeclidinium bromide, Umeclidinium
Commercialized according to BDPMDispensing in France: Prescription only
Powder for inhalation30 dosesinhalée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- INCRUSE ELLIPTA 55 microgrammes, poudre pour inhalation en récipient unidose
- Pharmaceutical form
- poudre pour inhalation
- Route of administration
- inhalée
- Presentation description
- plaquette(s) thermoformée(s) aluminium de 30 dose(s) avec 1 inhalateur(s)
- Marketing authorisation holder
- GLAXOSMITHKLINE TRADING SERVICES (IRLANDE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 4 Apr 2016
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68964304CIP73000464CIP133400930004647Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| UMÉCLIDINIUMpoudre | 55 microgrammes · une dose délivrée | FT |
| BROMURE D'UMÉCLIDINIUMpoudre | 65 microgrammes · une dose délivrée | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.